Previous Close | 5.26 |
Open | 5.20 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 5.08 - 5.25 |
52 Week Range | 2.51 - 6.40 |
Volume | |
Avg. Volume | 740,974 |
Market Cap | 3.795B |
Beta (5Y Monthly) | 1.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.33 |
Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.00 |
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of Curaleaf Miami North Biscayne, located at 2250 NE 163rd St. Suite 1, North Miami Beach, FL 33160. The location marks the Company's 62nd dispensary in Florida and 146th nationwide.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2024. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.
Curaleaf CEO Matt Darin said it was "a historic moment" for the cannabis industry following reports that the DEA is seeking to reschedule marijuana. Here are some of the implications for the weed industry.